Table 2.
Factors associated with the selection of an OAC over no OAC for stroke prevention in AF patients: multivariable logistic regression models.
| Factors | OAC Versus No OAC | ||
|---|---|---|---|
| OR | 95%CI | p | |
| Hospitalization due to electrical cardioversion | 6.02 | 3.32–10.89 | <0.001 |
| Hypertension | 1.40 | 1.01–1.95 | 0.049 |
| Age ≥ 75 | 1.06 | 0.82–1.36 | 0.701 |
| Myocardial infarction | 0.89 | 0.68–1.17 | 0.400 |
| Peripheral artery disease | 0.88 | 0.64–1.21 | 0.411 |
| Intracranial bleeding | 0.15 | 0.07–0.35 | <0.001 |
| Gastrointestinal bleeding | 0.25 | 0.17–0.37 | <0.001 |
| Cancer | 0.37 | 0.25–0.55 | <0.001 |
| Hospitalization due to acute coronary syndrome | 0.48 | 0.33–0.69 | <0.001 |
| Hemoglobin < 12 g/dL | 0.62 | 0.48–0.81 | <0.001 |
| eGFR < 60 mL/min/1.73 m2 | 0.86 | 0.67–1.11 | 0.238 |
Abbreviation: CI, confidence interval; eGFR, estimated glomerular filtration rate; OAC, oral anticoagulant; OR, odds ratio.